The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Natural History of HPV Infection across the Lifespan: Role of Viral Latency
Open accessAbstract
Large-scale epidemiologic studies have been invaluable for elaboration of the causal relationship between persistent detection of genital human papillomavirus (HPV) infection and the development of invasive cervical cancer. However, these studies provide limited data to adequately inform models of the individual-level natural history of HPV infection over the course of a lifetime, and particularly ignore the biological distinction between HPV-negative tests and lack of infection (i.e., the possibility of latent, undetectable HPV infection). Using data from more recent epidemiological studies, this review proposes an alternative model of the natural history of genital HPV across the life span. We argue that a more complete elucidation of the age-specific probabilities of the alternative transitions is highly relevant with the expanded use of HPV testing in cervical cancer screening. With routine HPV testing in cervical cancer screening, women commonly transition in and out of HPV detectability, raising concerns for the patient and the provider regarding the source of the positive test result, its prognosis, and effective strategies to prevent future recurrence. Alternative study designs and analytic frameworks are proposed to better understand the frequency and determinants of these transition pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Mercer, C. H., Tanton, C., Prah, P., Erens, B., Sonnenberg, P., Clifton, S., Macdowall, W., Lewis, R., Field, N., Datta, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62035-8 · Cited by 724
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Herbenick, D., Reece, M., Schick, V., Sanders, S. A., Dodge, B., & Fortenberry, J. D. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02012.x · Cited by 637
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
Burchell, A. N., Winer, R. L., de Sanjosé, S., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.031 · Cited by 529
Self-citationStrickler, H. D., Burk, R. D., Fazzari, M., Anastos, K., Minkoff, H., Massad, L. S., Hall, C., Bacon, M., Levine, A. M., Watts, D. H., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji073 · Cited by 519
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection
Brotman, R. M., Shardell, M. D., Gajer, P., Tracy, J. K., Zenilman, J. M., Ravel, J., & Gravitt, P. E. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu330 · Cited by 411
Self-citationThe known unknowns of HPV natural history
Gravitt, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57149 · Cited by 378
Self-citationCastellsagué, X., Muñoz, N., Pitisuttithum, P., Ferris, D., Monsonego, J., Ault, K., Luna, J., Myers, E., Mallary, S., Bautista, O. M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.185 · Cited by 347
Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S.-K., Kuypers, J., Kiviat, N., & Galloway, D. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.927 · Cited by 326
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Bosch, F. X., Robles, C., Díaz, M., Arbyn, M., Baussano, I., Clavel, C., Ronco, G., Dillner, J., Lehtinen, M., Petry, K.-U., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.146 · Cited by 206
Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women
Ho, G. Y. F., Studentsov, Y. Y., Bierman, R., & Burk, R. D. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0191 · Cited by 195
Wheeler, C. M., Skinner, S. R., Del Rosario-Raymundo, M. R., Garland, S. M., Chatterjee, A., Lazcano-Ponce, E., Salmerón, J., McNeil, S., Stapleton, J. T., Bouchard, C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30120-7 · Cited by 191
Viscidi, R. P., Schiffman, M., Hildesheim, A., Herrero, R., Castle, P. E., Bratti, M. C., Rodriguez, A. C., Sherman, M. E., Wang, S., Clayman, B., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0166 · Cited by 189
Johnston, C., & Corey, L. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-15 · Cited by 177
Maglennon, G. A., McIntosh, P., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.019 · Cited by 175
Safaeian, M., Porras, C., Schiffman, M., Rodriguez, A. C., Wacholder, S., Gonzalez, P., Quint, W., van Doorn, L.-J., Sherman, M. E., Xhenseval, V., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq384 · Cited by 173
Ho, G. Y. F., Studentsov, Y., Hall, C. B., Bierman, R., Beardsley, L., Lempa, M., & Burk, R. D. (2002) · The Journal of Infectious Diseases · doi:10.1086/342972 · Cited by 166
Trottier, H., Ferreira, S., Thomann, P., Costa, M. C., Sobrinho, J. S., Prado, J. C. M., Rohan, T. E., Villa, L. L., & Franco, E. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0621 · Cited by 158
Rositch, A. F., Burke, A. E., Viscidi, R. P., Silver, M. I., Chang, K., & Gravitt, P. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2635 · Cited by 146
Self-citationBeachler, D. C., Jenkins, G., Safaeian, M., Kreimer, A. R., & Wentzensen, N. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv753 · Cited by 140
Schiffer, J. T., Abu-Raddad, L. J., Mark, K. E., Zhu, J., Selke, S., Koelle, D. M., Wald, A., & Corey, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006614107 · Cited by 126
Gravitt, P. E., Rositch, A. F., Silver, M. I., Marks, M. A., Chang, K., Burke, A. E., & Viscidi, R. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis660 · Cited by 116
Self-citationImmunosuppression Facilitates the Reactivation of Latent Papillomavirus Infections
Maglennon, G. A., McIntosh, P. B., & Doorbar, J. (2013) · Journal of Virology · doi:10.1128/jvi.02589-13 · Cited by 99
Evidence and Impact of Human Papillomavirus Latency
Gravitt, P. E. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010198 · Cited by 96
Self-citationWang, S., SCHIFFMAN, M. H., Herrero, R., Carreon, J. D., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Morales, J., Guillén, D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602088 · Cited by 78
High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus–Infected Women
Theiler, R. N., Farr, S. L., Karon, J. M., Paramsothy, P., Viscidi, R. P., Duerr, A. C., Cu‐Uvin, S., Sobel, J. D., Shah, K. V., Klein, R. S., et al. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e00927 · Cited by 66
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects
Scherer, E. M., Smith, R. A. J., Gallego, D. F., Carter, J. J., Wipf, G. C., Hoyos, M., Stern, M. E., Thurston, T., Trinklein, N. D., Wald, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.042 · Cited by 60
Gage, J. C., Katki, H. A., SCHIFFMAN, M. H., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Castle, P. E., & Kinney, W. (2014) · International Journal of Cancer · doi:10.1002/ijc.29143 · Cited by 56
Prevalence and Incidence of HPV Genital Infection in Women
Velicer, C. M., Zhu, X., Vuocolo, S. C., Liaw, K., & Saah, A. J. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181ad25ff · Cited by 55
Ryser, M. D., Rositch, A. F., & Gravitt, P. E. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix333 · Cited by 49
Self-citationPolman, N. J., Veldhuijzen, N. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.309 · Cited by 48
Winer, R. L., Hughes, J. P., Feng, Q., Stern, J., Xi, L. F., & Koutsky, L. A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw074 · Cited by 45
Self-citationLiu, S., Cummings, D. A. T., Zenilman, J. M., Gravitt, P. E., & Brotman, R. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0666 · Cited by 44
Self-citationMalik, Z. A., Hailpern, S. M., & Burk, R. D. (2009) · Viral Immunology · doi:10.1089/vim.2009.0055 · Cited by 41
Episodic detection of human papillomavirus within a longitudinal cohort of young women
Shew, M. L., Ermel, A. C., Tong, Y., Tu, W., Qadadri, B., & Brown, D. R. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24284 · Cited by 39
Re‐detection vs. new acquisition of high‐risk human papillomavirus in mid‐adult women
Fu, T., Carter, J. J., Hughes, J. P., Feng, Q., Hawes, S. E., Schwartz, S. M., Xi, L. F., Lasof, T., Stern, J., Galloway, D. A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30283 · Cited by 37
Self-citationFranceschi, S., & Baussano, I. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu143 · Cited by 25
Menstrual Cycle and Detectable Human Papillomavirus in Reproductive-age Women: A Time Series Study
Liu, S., Brotman, R. M., Zenilman, J. M., Gravitt, P. E., & Cummings, D. A. T. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit337 · Cited by 17
Self-citationXi, L. F., Koutsky, L. A., Castle, P. E., Edelstein, Z. R., Hulbert, A., SCHIFFMAN, M. H., & Kiviat, N. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/657083 · Cited by 12
Baay, M. F. D., François, K., Lardon, F., Royen, P. V., Pauwels, P., Vermorken, J. B., Peeters, M., & Verhoeven, V. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.10.005 · Cited by 11
Cited by
The microbiome and gynaecological cancer development, prevention and therapy
Łaniewski, P., Ilhan, Z. E., & Herbst-Kralovetz, M. M. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0286-z · Cited by 450
Joshi, S., Muwonge, R., Kulkarni, V., Mandolkar, M., Lucas, E., Pujari, S., Sankaranarayanan, R., & Basu, P. (2023) · International Journal of Cancer · doi:10.1002/ijc.34221 · Cited by 12
Metadata
- Authors
- Gravitt, P., & Winer, R.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2017-09-21
- Volume
- 9
- Issue
- 10
- Pages
- 267
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2758767377
- Cited by
- 262
- References
- 44
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.